DRI Healthcare Trust (DHT-UN) Q2 2024 earnings summary

Executive summary

• Leadership changes implemented following discovery of irregular consulting and other expenses, with new CEO and CFO appointed and further management changes effective September 2024; Gary Collins named CEO and Amit Kapur or Sandy Kwan as CFO.

• Internal investigation into expense irregularities is substantially complete, with all misappropriated expenses reimbursed and no impact on cash royalty receipts.

• Internal controls and governance processes are under comprehensive review, with restated 2022 and 2023 financials and related disclosures filed.

• Business performance remains strong, with robust execution on strategy, continued capital deployment, and a robust pipeline of over $3.2 billion in potential opportunities.

• Focus on deal execution, capital allocation, and unitholder returns, supported by strengthened governance.

Financial highlights

• Q2 2024 normalized total cash receipts reached $43.0 million, up 50% year-over-year, the highest since IPO.

• Total income for Q2 2024 was $41.6 million, a 48% increase year-over-year.

• Adjusted EBITDA was $32.9 million, up 31% year-over-year, with a margin of 77%.

• Adjusted cash earnings per unit were $0.49 for Q2 2024 and $2.47 for the last twelve months; quarterly dividend of $0.085 declared.

• Last 12 months ended June 30, 2024: normalized total cash receipts $184 million, adjusted EBITDA $155.8 million (margin 85%).

Outlook and guidance

• 2024 royalty income guidance (excluding milestones and new transactions): $153–$155 million, up from $117.5 million in 2023 on a comparable basis.

• High teens royalty income CAGR expected through 2025; mid to high single-digit CAGR through 2030.

• Deployment target reiterated at over $1.25 billion for the five years ending 2025, up from the original $650–$750 million.

• Portfolio duration extended to over 10 years, supported by equity offerings and credit facilities.

• Management expresses optimism for continued growth and value creation for unitholders, supported by a robust business model.